Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VISX -- Ignore unavailable to you. Want to Upgrade?

To: Thai Chung who wrote (1385)	11/12/1999 9:15:00 AM
From: Feathered Propeller	Read Replies (1) \| Respond to of 1754

FWIW: From CNBC 11/12/99 - 8:43:21 AM ...Visx on the research front this morning. Bank america, montgomery adds that stock as a buy. Visx in the business of fixing cure eye site. More and more people, first hand who have date of birth it, and we're talking about -- domestic market that doubled in 1999 to about 910,000 eyes. Generating fee revenue to manufacturers of around 220 million, bank america expects it will get to 1.4 Million sighs, -- eyes, so that would be 700,000 people. Most likely. Don't know how many one-eyed people there are. Mark or people who have just one eye done. David: That is true, mark, i guess you can have only one eye done. They do it per eye, charged last time like 2500 and eye. Prices may have started to come down. It was 5 grand tore two eyes or 2500 for one. Not a big deal. You think a discount if do you two or four. Joe: Because people do get --. Mark: Louie says no what. >> No discount. Joe: Get one fix for near sightedness and get the other he if you can see close up up, like having a buy focal. People turn in circles, over ... They do have fun at that station...